We are pleased to announce that the Journal of Pharmaceutical and BioTech Industry (JPBI, ISSN: 2813-9380) has established a companionship with its sister journal, Pharmaceutics (ISSN: 1999-4923).
The Journal of Pharmaceutical and BioTech Industry is an international, peer-reviewed, and open access journal committed to publishing research and development studies on all aspects of science, engineering, and technology applicable to the pharmaceutical and biotech industry sectors, published quarterly online by MDPI. The founding Editor-in-Chief is Prof. Dr. Ecevit Bilgili from the New Jersey Institute of Technology, USA.
The Journal of Pharmaceutical and BioTech Industry aims to create a platform on which scientists and engineers from academia, industry, and regulatory as well as other governmental agencies share and complement each other’s discoveries and advance science, engineering, and technology with the goal of enhancing patient wellbeing. All aspects of the discovery, development, delivery, and manufacturing of drugs (drug substances and drug products, including biodrugs, delivery devices, diagnostic agents, etc.) are covered. We accept original research articles, critical and timely reviews, short communications, opinions, technical notes, reports, and expert perspectives. For details on the background and scope of this journal, please click on the following link: https://www.mdpi.com/journal/jpbi/about.
We offer a full waiver on article processing charges for papers submitted before 1 January 2025. Manuscripts are peer-reviewed and a first decision is provided to authors approximately 16 days after submission; acceptance to publication is undertaken in 5.8 days (median values for MDPI journals in the first half of 2024). If accepted after peer review, your paper will be published in an open access format.
Manuscripts can be submitted via the journal’s online submission system at the following link: https://susy.mdpi.com/user/manuscripts/upload?journal=jpbi.
You can read the Opening Editorial by the Editor-in-Chief at the following link: https://www.mdpi.com/2813-9380/1/1/3.
You can read the short interview with Prof. Dr. Ecevit Bilgili, the Editor-in-Chief, who shared his vision for the journal with us, as well as his views of the area and open access publishing: https://www.mdpi.com/journal/jpbi/announcements/9313.
We cordially invite you to consider the Journal of Pharmaceutical and BioTech Industry as the platform for publishing your work.
JPBI Editorial Office
